𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics and pharmacodynamics analysis of transdermal iontophoresis of 5-OH-DPAT in rats: In vitro–in vivo correlation

✍ Scribed by Akhmad Kharis Nugroho; Stefan G. Romeijn; Raphaël Zwier; Jan B. de Vries; Durk Dijkstra; Håkan Wikström; Oscar Della-Pasqua; Meindert Danhof; Joke A. Bouwstra


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
462 KB
Volume
95
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis


Pharmacokinetics and dopaminergic effect of dopamine agonist 5-OH-DPAT in vivo were determined following transdermal iontophoresis in rats based on drug concentration in plasma (C(p)) and dopamine levels in striatum (C(DA)). Correlation of the in vitro transport with the pharmacokinetic-pharmacodynamic (PK-PD) profiles was characterized in the transport in dermatomed rat skin (DRS) and rat stratum corneum (RSC). The integrated in vivo PK-PD and in vitro transport models successfully described time course of C(p), C(DA), and in vitro flux in DRS and RSC. Population value of steady-state flux (J(ss)) in vivo (31 nmol/cm(2) . h with 95% confidence interval (CI) = 20-41) is closer to J(ss) in vitro in DRS (61 nmol/cm(2) . h, CI = 54-67) than in vitro J(ss) in RSC (98 nmol/cm(2) . h, CI = 79-117). On the other hand, skin release rate constant (K(R)) in vivo was similar to the K(R) in RSC (4.8/h, CI = 2.4-7.1 vs. 2.6/h, CI = 2.5-2.6). Kinetic lag time (t(L)) in vivo was negligible, which is close to in vitro t(L) in RSC (0.0 h, CI = 0.0-0.1). Based on nonlinear mixed-effect modeling, profiles of C(p) and C(DA) were successfully predicted using in vitro values of J(ss) in DRS with K(R) and t(L) in RSC. A considerable dopaminergic effect was achieved, indicating the feasibility to reach therapeutically effective concentrations of 5-OH-DPAT upon transdermal iontophoresis.


📜 SIMILAR VOLUMES


Mechanistic studies of the transdermal i
✍ Oliver W. Ackaert; Jeroen Van Smeden; Jeroen De Graan; Durk Dijkstra; Meindert D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

A characterization and optimization of the in vitro transdermal iontophoretic transport of 5-hydroxy-2-(N,N,-di-n-propylamino)tetralin (5-OH-DPAT) is presented. The utility of acetaminophen as a marker of electroosmotic flow was studied as well. The following parameters of iontophoretic transport of

The study of in vitro–in vivo correlatio
✍ Teerapol Srichana; Roongnapa Suedee; Det Muanpanarai; Niwan Tanmanee 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

The pharmacokinetics and pharmacodynamics of albuterol were studied following inhalation of three different in-house dry powder formulations in healthy volunteers and in asthmatics. Albuterol in plasma was measured using liquid chromatography-mass spectrometry (LC-MS). The plasma concentration time

Effects of 8-OH-DPAT on hippocampal NADH
✍ Andre Rex; H. Fink 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Systemic administration of the 5-HT1A receptor agonist 8-OH-DPAT modifies 5-HT neuronal transmission via stimulation of presynaptic and postsynaptic receptors. Compared to the effects of presynaptic receptor stimulation, there are less data on the effects of postsynaptic 5-HT1A receptors and the net

Effect of surfactants on percutaneous ab
✍ Z. T. Chowhan; R. Pritchard; W. H. Rooks II; A. Tomolonis 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB 👁 1 views

The effect of surfactants on percutaneous absorption of naproxen was studied using rat in vivo models. The in vivo normalized relative absorption rates were in good agreement with the in vitro relative flux. An antipyretic model in the rat could not show relatively small increases in percutaneous ab

Pharmacokinetics and pharmacodynamics of
✍ Yu C. Kim; Eun Y. Oh; So H. Kim; Myung G. Lee 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

The pharmacokinetic and pharmacodynamic parameters of torasemide were compared after intravenous administration at a dose of 2 mg/kg to diabetic rats induced by alloxan (DMIA) or streptozotocin (DMIS), and their respective control rats. It was reported that torasemide was mainly metabolized via CYP2